PulseLife Acquires Invivox to Forge a European Healthcare Technology Giant Combining AI Decision-Support with Continuous Medical Education

The landscape of European digital health is undergoing a monumental shift as French medtech pioneer PulseLife, operating under the 360 Medical group, officially announces the strategic acquisition of Invivox, the continent’s leading platform for continuous medical education (CME) and healthcare professional engagement. This high-profile acquisition bridges two critical pillars of modern clinical practice: instant, evidence-based decision support at the point of care, and long-term, specialized professional development. By bringing these two platforms together, the newly formed entity creates an integrated European powerhouse designed to assist medical practitioners across the entire continuum of their professional lives.

The transaction unites two of France’s most innovative and respected health-tech scale-ups. PulseLife has built a massive footprint with its evidence-based and sovereign medical AI chatbot, which is currently relied upon by more than 900,000 healthcare professionals worldwide—including 420,000 physicians, 220,000 nurses, and 43,000 pharmacists. Meanwhile, Invivox has spent nearly a decade establishing itself as the gold standard in digital companionship and continuous medical training, connecting practitioners globally to elite experts and specialized medical centers. Together, they aim to capture the European market and establish a unified standard for medical knowledge by 2029.

The Chronology of Innovation and Strategic Convergence

To understand the weight of this acquisition, one must examine the respective trajectories of both companies over the past decade. PulseLife was founded in Lyon in 2014 by Dr. Grégoire Pigné, Clotilde Petit, and Romain Bruckert. From its inception, the company focused on alleviating the cognitive burden placed on clinicians by providing immediate access to verified, reliable, and continuously updated medical knowledge. Over the years, PulseLife evolved from a digital documentation tool into a sophisticated decision-support ecosystem, culminating in the 2024 adoption of a company-with-a-mission status, solidifying its commitment to accessible healthcare excellence.

Invivox entered the e-health arena shortly after in 2016, identifying a critical gap in how doctors, surgeons, and specialists update their practical skills. Traditional medical education was often fragmented, geographic-bound, and slow to adapt to modern technological workflows. Invivox pioneered a model of digital companionship and immersive training that allowed nearly a million healthcare workers over the past ten years to bridge the gap between theoretical knowledge and practical surgical or clinical execution.

The convergence of these two entities did not happen in a vacuum. In recent years, PulseLife experienced exponential growth driven by the integration of artificial intelligence into its clinical workflows. Deploying its proprietary medical chatbot—built in close collaboration with learned societies and institutional health bodies—the tool quickly became a staple across prominent French healthcare institutions such as the Assistance Publique – Hôpitaux de Paris (AP-HP), the Hospices Civils de Lyon, and forthcoming integrations at the Reims University Hospital (CHU de Reims). As the platform expanded beyond France into Spain and prepared for a rollout in the United Kingdom, leadership identified both a monumental opportunity and a nascent industry-wide challenge.

Combating the Threat of Clinical Deskilling Through AI Integration

The rapid deployment of generative artificial intelligence and clinical decision-support systems in medicine has brought forth unprecedented efficiencies, but it has also triggered a growing psychiatric and operational concern known as "deskilling." Medical ethicists, hospital administrators, and practicing physicians have expressed growing anxiety that an over-reliance on automated systems might lead to the gradual atrophy of a clinician’s critical thinking, independent diagnostic capabilities, and procedural competence.

PulseLife and Invivox are positioning their newly combined ecosystem as a direct, proactive antidote to this phenomenon. Rather than allowing artificial intelligence to act as a crutch that replaces human expertise, the integrated platform transforms every clinical query into an active educational opportunity.

Under the newly designed architecture, when a healthcare professional uses PulseLife’s medical AI chatbot to resolve an immediate clinical doubt—such as determining the correct therapeutic protocol in emergency medicine, internal medicine, or gynecology—the interaction does not end with a passive answer. If the system detects recurring inquiries on a specific subject, or if the clinical context warrants deeper mastery, the platform seamlessly suggests targeted Invivox training modules. This approach ensures that clinicians remain active masters of their own knowledge base, using AI not to delegate clinical responsibility, but to pinpoint exact areas where their professional competencies can be systematically reinforced.

A Seamless Continuum: Bridging the Gap Between Decision-Making and Lifelong Learning

Historically, the daily workflow of a physician or nurse has been fractured by a divide between immediate operational necessities and long-term professional development. When faced with a complex patient presentation, a clinician typically asks: "What is the immediate course of action?" This requires instantaneous decision support. However, once the immediate crisis is averted, the practitioner often harbors a deeper educational need to fully master a new medical device, surgical technique, or evolving treatment guideline.

Until now, these two requirements—instantaneous clinical decision support and continuous professional education—were handled by entirely disparate toolsets, software applications, and institutional frameworks. PulseLife and Invivox have effectively dismantled these silos.

By embedding Invivox’s rich repository of training content directly into the PulseLife interface, the decision-support tool evolves from a static answer engine into a dynamic gateway for skill enhancement. Depending on the clinical guidelines consulted, the decision trees navigated, or the specific patient case analyzed, the system intelligently recommends relevant educational modules. These modules may either be readily available on Invivox or developed specifically to address emerging clinical trends. Consequently, continuous medical education is no longer viewed as a mandatory administrative checkbox fulfilled through periodic seminars, but rather as an organic extension of daily clinical practice.

Immediate Benefits for the Global Healthcare Workforce

The merger yields direct, tangible advantages for medical practitioners operating across various tiers of the healthcare system:

• Unbroken Continuity Between Deciding and Learning: Clinicians can transition seamlessly in just a few clicks from resolving an acute clinical dilemma to engaging with the exact educational content required to master the underlying condition.
• Absolute Reliability and Provenance: All information, decision pathways, and training modules remain strictly anchored in validated guidelines issued by official health authorities and accredited learned societies.
• Hyper-Personalized Educational Pathways: Training suggestions are not generic; they are context-aware, triggered precisely when a practitioner encounters a specific clinical scenario in their real-world practice.
• Pan-European Ecosystem Expansion: Practitioners gain access to an expanded network that merges advanced digital decision support with peer-to-peer digital companionship on a continental scale.

Official Perspectives and Leadership Vision

The executive leadership behind both organizations view the acquisition as a defining milestone for European health technology sovereignty.

Clotilde Petit, Chief Executive Officer and co-founder of PulseLife, emphasized the philosophical alignment of the merger regarding the ethical deployment of artificial intelligence in healthcare:
"Medical knowledge already exists: learned societies and experts produce it every single day. The core challenge has always been ensuring that this knowledge reaches the clinician on time, wherever they happen to be practicing. For over a decade, PulseLife has helped clinicians find the right answer at the moment they need it, and artificial intelligence now makes those answers virtually instantaneous. By uniting PulseLife and Invivox, we are adding a fundamental conviction: AI must reinforce clinician expertise, not replace it. With Invivox, every question asked becomes an opportunity to learn."

Echoing this sentiment, Julien Delpech and Patxi Ospital, co-founders of Invivox, highlighted the growth acceleration provided by the partnership:
"Being acquired by PulseLife serves as a powerful accelerator for Invivox, enabling us to fulfill our founding mission on a much broader, universal scale: the continuous, lifelong training of healthcare professionals through digital companionship."

Broader Industry Implications and the Road to 2029

The creation of this integrated European health-tech champion arrives at a crucial juncture for European healthcare systems. Across the European Union, health sectors are grappling with severe staffing shortages, chronic burnout, and the administrative burdens associated with mandatory continuous medical education. By streamlining knowledge acquisition and embedding training into daily workflows, tools like the combined PulseLife-Invivox platform have the potential to significantly alleviate professional strain while simultaneously driving up the overall quality and safety of patient care.

Furthermore, the acquisition underscores the growing strategic value of European technological sovereignty. In an era dominated by foreign technology conglomerates, the union of two homegrown French scale-ups—built upon strict adherence to European data privacy standards, sovereign medical databases, and validated clinical guidelines—establishes a robust precedent for the digital transformation of healthcare across the continent.

Looking ahead, the leadership team has set an ambitious benchmark: to become the undisputed reference standard for European medical knowledge by the year 2029. As the newly integrated platform expands its deployment across France, Spain, the United Kingdom, and beyond, it promises to redefine how millions of doctors, nurses, and allied health professionals acquire, maintain, and apply their medical expertise in an increasingly complex world.